The popularity of Viagra initially fueled a surge for major pharmaceutical companies, but recent changes present a murky scenario for investors. Off-patent alternatives are eroding revenue, and ongoing patent https://sahilslgf657543.blogsvila.com/41515132/sildenafil-and-big-pharma-a-volatile-bet